TEL: 616.808.2695 | FAX: 616.808.2697
1959 EAST PARIS AVE SE, GRAND RAPIDS, MI 49546
DSIP Peptide



DSIP Peptide
DSIP or Delta Sleep Inducing Peptide is a nonapeptide that is recognized for its effects on promoting sleep. D-SIP regulates sleep patterns by shortening the time to fall asleep and extends the duration and quality of sleep. DSIP also has positive physiological benefits on the entire body with effects on the endocrine system, cardiovascular system, and neurotransmitter function.
How Does DSIP Improve Sleep
DSIP binds to receptors in multiple sites of the brain and brain stem that are associated with inducing sleep. It increases the production of the neurotransmitter GABA that calms the brain and promotes relaxation and deeper sleep. D-SIP also interacts with the hormones serotonin and melatonin which are involved in the induction of sleep and regulation of sleep patterns.
Research on DSIP has shown results of inducing sleep in patients with insomnia and improving the duration of time spent in slow wave restorative sleep patterns. DSIP is different from sleep medications because it does not change the tie or duration of sleep cycles which are important for a variety of physiological processes and anabolic hormone production.
DSIP does not change sleep stages, but increases the ability to go to sleep and stay into a deeper more restful sleep.
How Does D-SIP Improve Hormone Functions
DSIP has an effect on neuroendocrine regulation and release of anterior pituitary hormones. DSIP influences the secretion of adrenocorticotropic hormone (ACTH), luteinizing hormone (LH), and growth hormone (GH). Administration of DSIP improves the regulation and production of hormones in these glands by increasing production of LH and GH, while decreasing the production of undesirable ones like cortisol and somatostatin.
DSIP also plays a role in the regulation of circadian rhythms.
DSIP BENEFITS
-
Improve Ability to Fall Asleep
-
Improve Sleep Quality
-
Improve Sleep Patterns
-
Restore Circadian Rhythm Cycles
-
Modulate and Decrease Cortisol Production
-
Promote Growth Hormone (GH) and Luteinizing Hormone (LH) Release
-
Reduce Chronic Pain
-
Lower Blood Pressure
-
Lower Risk of Heart Disease
-
Decrease Anxiety and Depression
-
Increase Stress Resilience
-
Boost Cognitive Function
DSIP Administration
DSIP Dosing:
DSIP is administered by sublingual mouth spray under the tongue. Recommended starting dosage is 5 sprays under the tongue 30 minutes prior to sleep. If needed administer another 3 to 5 sprays immediately before going to sleep. DSIP does not have to be cycled and is recommended to be used nightly on a consistent basis for best results
DSIP Side Effects:
Side effects of DSIP may include headaches, dizziness, nausea, and stomach pain. Side effects are typically mild and subside independently without intervention. DSIP is not recommended for people that are pregnant or breast feeld
Disclaimer:
Individual results vary. Best results obtained with combination of a healthy diet and lifestyle . These products nor the ingredients have been approved or endorsed by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. Homeopathic products have not been reviewed by the FDA for safety and effectiveness to diagnose, treat, cure, or prevent any disease or conditions. These are compounded by a US compounding pharmacy that provides these for physician prescribed patient-specific use only. You should consult a licensed health care professional before starting any peptide, supplement, dietary, or exercise program. Products not recommended if you are pregnant or breast feeding.

DSIP Therapy FAQ
1. What is DSIP peptide?
DSIP, or Delta Sleep-Inducing Peptide, is a peptide that has been studied for its potential effects on sleep and sleep-wake regulation. Research has investigated DSIP in relation to sleep quality, sleep duration, stress responses, and other neurological functions.
2. What are the potential benefits of DSIP peptide?
Potential benefits investigated in research include sleep support, sleep quality, relaxation, and sleep-wake regulation. Some older human studies reported improvements in certain measures of sleep, although other studies found limited or inconsistent clinical benefits.
3. How does DSIP peptide work?
The exact mechanism of DSIP is not fully understood. Research suggests that DSIP may influence processes involved in sleep regulation and the sleep-wake cycle, but its precise biological mechanism in humans remains uncertain.
4. Can DSIP peptide help with sleep?
DSIP has been investigated for its potential effects on sleep. Some small clinical studies reported improvements in sleep efficiency, sleep latency, or aspects of sleep structure.
5. Does DSIP peptide help with insomnia?
DSIP has been studied in people with chronic insomnia. Several older clinical studies reported improvements in sleep, but the studies were generally small and the overall evidence is not sufficient to establish DSIP as a proven treatment for insomnia.
6. Does DSIP peptide improve sleep quality?
Research has investigated DSIP's effects on sleep quality, sleep efficiency, nighttime awakenings, and sleep architecture. Some studies reported improvements, but results have not been consistent across clinical trials.
7. What are the side effects of DSIP peptide?
The potential side effects of DSIP may include headaches, dizziness, nausea, and stomach pain. Side effects are typically mild and subside independently without intervention. DSIP peptide is not recommended if the patient is pregnant or breast feeding. Older studies reported relatively good short-term tolerance, but this does not establish the long-term safety of DSIP or currently compounded formulations.
8. Is DSIP peptide safe?
The safety of DSIP has not been adequately established by modern clinical trials. The FDA has specifically identified concerns regarding compounded emideltide (DSIP), including potential immunogenicity, peptide-related impurities, and uncertainty regarding safety for proposed routes of administration. DSIP should only be used under physician guidance.
9. Is DSIP peptide FDA approved?
DSIP is not an FDA-approved treatment for insomnia, sleep problems, stress, or general wellness.
10. What is the difference between DSIP and sleeping pills?
DSIP is a peptide that has been investigated for its effects on sleep regulation, while conventional sleeping medications include several different drug classes with established pharmacological mechanisms and FDA-approved indications. DSIP should not be considered equivalent to an FDA-approved prescription sleep medication.
11. Does DSIP cause daytime drowsiness?
Some early human research reported sleep-promoting effects without conventional daytime sedation, but responses may vary and the available evidence is limited.
12. How is DSIP peptide administered?
DSIP is administered at Age Management of West Michigan by sublingual spray that is administered under the tongue to optimize absorption and promote positive treatment response at lower dosages. AMWM recommends no food or beverages for at least 10 minutes after administration for optimal absorption.
13. What is the recommended DSIP peptide dosage?
There is no FDA-approved standard dosage for DSIP peptide therapy. AMWM recommends of dosing of 5 to 7.5mcg nightly before bed. Age Management of West Michigan uses a homeopathic sublingual spray form of DSIP peptide to promote optimal absorption and treatment effect at lower dosages.
14. How can DSIP peptide improve deep sleep?
Research shows that Delt Sleep-Inducing Peptide binds to receptors in multiple sites of the brain and brain stem that are associated with inducing sleep. It increases the production of the neurotransmitter GABA that calms the brain and promotes relaxation and deeper sleep. DSIP also interacts with hormones serotonin and melatonin which are involved in the induction of sleep and regulation of sleep patterns. Research on DSIP has shown results of inducing sleep in some patients with insomnia and improving the duration of time spent in slow wave restorative sleep patterns. DSIP should only be used under physician guidance
15. Can DSIP peptide help regulate the sleep-wake cycle?
Sleep-wake regulation is one of the primary areas investigated in DSIP research. Early studies suggested that DSIP may influence sleep-wake behavior and circadian-related processes, but the precise mechanisms and clinical significance remain uncertain. DSIP is different from sleep medications because it does not change the time or duration of sleep cycles which are important for a variety of physiological processes and anabolic hormone production. DSIP does not change sleep stages, but increases the ability to go to sleep and stay into a deeper more restful sleep.
16. Is DSIP peptide a natural peptide?
Delta-sleep-inducing peptide (DSIP) is found in several regions of the body, but science has not yet confirmed exactly where or how it is synthesized (produced). Researchers have detected DSIP in both free and bound forms across multiple organs, tissues, and fluids:
-
Brain and Central Nervous System: The Hypothalamus, limbic system, and pituitary gland.
-
Endocrine and Peripheral Organs: Abundant in gut secretory cells, the pancreas (co-localizing with glucagon), and the adrenal glands.
-
Body Fluids: Present in blood plasma, cerebrospinal fluid, and human breast milk
DSIP treatment that is offered at Age Management of West Michigan is a compounded synthetic form that is identical to the natural nonapeptide produced in the human body.
17. Is DSIP the same as melatonin?
No. DSIP and melatonin are different substances. Melatonin is a hormone involved in regulating circadian rhythms, while DSIP is a peptide that has been investigated for potential effects on sleep and sleep-wake regulation. DSIP does have physiological interaction with melatonin in the body.
18. What are the side effects of DSIP peptide?
Side effects of DSIP may include headaches, dizziness, nausea, and stomach pain. Side effects are typically mild and subside independently without intervention. A healthcare professional should determine whether DSIP therapy is appropriate for an individual. All peptide treatments at Age Management of West Michigan are physician prescribed after complete evaluation that may include medical history, current medications, health goals, existing conditions, and available evidence regarding potential benefits and risks.
19. Is DSIP peptide therapy right for everyone?
No. DSIP is not appropriate for everyone. A healthcare professional should determine whether BPC-157 peptide therapy is appropriate for an individual. All peptide treatments at Age Management of West Michigan are physician prescribed after complete evaluation that may include medical history, current medications, health goals, existing conditions, and available evidence regarding potential benefits and risks.
20. Where can I get DSIP therapy in Grand Rapids, MI?
Age Management of West Michigan provides physician-guided peptide therapy in Grand Rapids, Michigan. DSIP may be considered as part of an individualized sleep management and healthy aging protocol. A FREE peptide consultation can help determine whether MOTS-c is appropriate based on your goals and medical history. All peptide treatments at Age Management of West Michigan are physician prescribed after complete evaluation that may include medical history, current medications, health goals, existing conditions, and available evidence regarding potential benefits and risks.
21. How do I get started with DSIP therapy?
The first step is a FREE Peptide consultation with a qualified medical professional at Age Management of West Michigan to discuss your goals, medical history, current medications and whether DSIP is an appropriate option. Then an appointment for physician clearance is scheduled and individualized peptide protocol will be prescribed.
Research and References
-
Schoenenberger GA (1984). "Characterization, properties and multivariate functions of Delta-Sleep Inducing Peptide (DSIP)". European Neurology. 23 (5): 321–345. doi:10.1159/000115711. PMID 6548966
-
Iyer KS, McCann SM (November 1987). "Delta sleep inducing peptide (DSIP) stimulates the release of LH but not FSH via a hypothalamic site of action in the rat". Brain Research Bulletin. 19 (5): 535–538. doi:10.1016/0361-9230(87)90069-4. PMID 3121137. S2CID 7710977
-
Koval'zon VM (1994). "[DSIP: the sleep peptide or an unknown hypothalamic hormone?]". Zhurnal Evoliutsionnoi Biokhimii I Fiziologii (in Russian). 30 (2): 310–319. PMID 7817664
-
Sudakova KV, Coghlan JP, Kotov AV, Salieva RM, Polyntsev YV, Koplik EV (1995). "Delta-sleep inducing peptide sequels in mechanisms of resistance to emotional stress". Annals of the New York Academy of Sciences. 771 (1): 240–251. Bibcode:1995NYASA.771..240S
-
Khvatova EM, Samartzev VN, Zagoskin PP, Prudchenko IA, Mikhaleva II (2003). "Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia". Peptides. 24 (2): 307–311. doi:10.1016/S0196-9781(03)00040-8. PMID 12668217
-
Seifritz E, Muller M, Schonenberger G, Trachsel L, Hemmeter U, Hatzinger M, Ernst A, Moore P, Holsboer-Trachsler E (1995). "Human plasma DSIP decreases at the initiation of sleep at different circadian times". Peptides. 16 (8): 1475–1481. doi:10.1016/0196-9781(95)02027-6. PMID 8745061. S2CID 40634977
-
Steiger A, Holsboer F (1997). "Neuropeptides and human sleep". Sleep. 20 (11): 1038–1052. PMID 9456470
-
Westrin A, Ekman R, Traskman-Bendz L (1998). "High Delta Sleep-Inducing Peptide-Like Immunoreactivity in Plasma in Suicidal Patients with Major Depressive Disorder". Biological Psychiatry. 43 (10): 734–739. doi:10.1016/S0006-3223(97)00254-0
-
Walleus H, Widerlöv E, Ekman R (1985). "Decreased concentrations of delta-sleep inducing peptide in plasma and cerebrospinal fluid from depressed patients". Nordic Journal of Psychiatry. 39: 63–67. doi:10.3109/08039488509101959
-
Schneider-Helmert D (1986). "DSIP in Sleep Disturbances". Eur Neurol. 25 (2): 154–157. doi:10.1159/000116097. PMID 3758119
-
Schneider-Helmert D, Schoenenberger GA (1981). "The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep". Cellular and Molecular Life Sciences. 37 (9): 913–917. doi:10.1007/BF01971753. PMID 7028502
